http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7775695

Outgoing Links

Predicate Object
contentType Clinical Trial|Journal Article|Multicenter Study|Randomized Controlled Trial
endingPage 95
issn 0920-1211
issueIdentifier 2-3
pageRange 89-95
publicationName Epilepsy Research
startingPage 89
bibliographicCitation Grant R, Shorvon SD. Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy. Epilepsy Res. 2000 Dec;42(2-3):89–95. doi: 10.1016/s0920-1211(00)00158-3. PMID: 11074181.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f012908d886ca355add4ac81ef79a4de
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b3fbc40853976a98837112498385fb2
date 200012
identifier https://pubmed.ncbi.nlm.nih.gov/11074181
https://doi.org/10.1016/s0920-1211%2800%2900158-3
isPartOf https://portal.issn.org/resource/ISSN/0920-1211
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Efficacy and tolerability of 1000–4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy
discusses http://id.nlm.nih.gov/mesh/M0001382
http://id.nlm.nih.gov/mesh/M0374035
http://id.nlm.nih.gov/mesh/M0016891
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D004827Q000188
http://id.nlm.nih.gov/mesh/D010889Q000031
http://id.nlm.nih.gov/mesh/D000927Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D010889Q000008
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D016037
http://id.nlm.nih.gov/mesh/D018709
http://id.nlm.nih.gov/mesh/D010865
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000077287
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6654
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6522
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284583
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6983

Total number of triples: 41.